Post Marketing Surveillance

Post-marketing surveillance (PMS) is a critical phase of pharmaceutical regulatory science, focusing on monitoring the safety of medications after they are released on the market. It helps in identifying and evaluating previously unreported adverse effects and interactions, ensuring the ongoing assessment of the risk-benefit balance of drugs. PMS data contribute to updating drug labels, informing healthcare professionals and the public, and may lead to regulatory actions such as modifying dosage recommendations or withdrawing drugs if necessary.

Post-marketing surveillance (PMS) is a vital phase in the lifecycle of pharmaceutical products, aimed at ensuring their ongoing safety once they have entered the market. Through PMS, regulatory authorities and drug manufacturers collect and analyze real-world data on adverse drug reactions, thereby gaining insights into the drug's performance in a broader patient population. This continuous monitoring helps in identifying rare or long-term side effects not detected during the initial clinical trials, ensuring that healthcare professionals and patients are informed about the benefits and risks of medications, leading to safer use of drugs.

    Related Conference of Post Marketing Surveillance

    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy

    Post Marketing Surveillance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in